Weight loss varies by state
FCPS: With the removal of HealthKeepers effective March 1, 2026, will we still experience provider participation issues
What the FDA Has Actually Approved for Weight Management The National Institute of Diabetes and Digestive and Kidney Diseases maintains a plain-language list of prescription medications approved for chronic weight management: orlistat (Xenical, Alli), phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound), plus setmelanotide (Imcivree) for specific rare genetic causes of obesity
Role of glucagon-like peptide-1 (GLP-1) receptor agonists in cardiovascular risk management in patients with type 2 diabetes mellitus: a systematic review
Rudnicka E, et al
Key variants in the GLP1R gene (like rs6923761) and the FTO gene (rs9939609) influence both your baseline hunger set point and your medication responsiveness